145 related articles for article (PubMed ID: 20214982)
21. Antiproliferative Activity of Double Point Modified Analogs of 1,25-Dihydroxyvitamin D₂ Against Human Malignant Melanoma Cell Lines.
Piotrowska A; Wierzbicka J; Nadkarni S; Brown G; Kutner A; Żmijewski MA
Int J Mol Sci; 2016 Jan; 17(1):. PubMed ID: 26760999
[TBL] [Abstract][Full Text] [Related]
22. Targeting components of the stress system as potential therapies for the metabolic syndrome: the peroxisome-proliferator-activated receptors.
Yumuk VD
Ann N Y Acad Sci; 2006 Nov; 1083():306-18. PubMed ID: 17148746
[TBL] [Abstract][Full Text] [Related]
23. PPARs as new therapeutic targets for the treatment of cerebral ischemia/reperfusion injury.
Collino M; Patel NS; Thiemermann C
Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):179-97. PubMed ID: 19124421
[TBL] [Abstract][Full Text] [Related]
24. Molecular mechanism of 1,25-dihydroxyvitamin D3 inhibition of adipogenesis in 3T3-L1 cells.
Kong J; Li YC
Am J Physiol Endocrinol Metab; 2006 May; 290(5):E916-24. PubMed ID: 16368784
[TBL] [Abstract][Full Text] [Related]
25. Targets of vitamin D receptor signaling in the mammary gland.
Welsh J
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V86-90. PubMed ID: 18290729
[TBL] [Abstract][Full Text] [Related]
26. Cardiovascular disease in chronic kidney failure: the role of VDR activators.
Wu-Wong JR; Tian J; Nakane M; Ma J; Fey TA; Kroeger P; Fryer RM; Reinhart GA
Curr Opin Investig Drugs; 2006 Mar; 7(3):206-13. PubMed ID: 16555680
[TBL] [Abstract][Full Text] [Related]
27. Regulation of energy metabolism by long-chain fatty acids.
Nakamura MT; Yudell BE; Loor JJ
Prog Lipid Res; 2014 Jan; 53():124-44. PubMed ID: 24362249
[TBL] [Abstract][Full Text] [Related]
28. A genomic perspective on vitamin D signaling.
Carlberg C; Seuter S
Anticancer Res; 2009 Sep; 29(9):3485-93. PubMed ID: 19667142
[TBL] [Abstract][Full Text] [Related]
29. Peroxisome proliferator-activated receptor-gamma ligands as cell-cycle modulators.
Theocharis S; Margeli A; Vielh P; Kouraklis G
Cancer Treat Rev; 2004 Oct; 30(6):545-54. PubMed ID: 15325034
[TBL] [Abstract][Full Text] [Related]
30. PPARs: therapeutic targets for metabolic disease.
Berger JP; Akiyama TE; Meinke PT
Trends Pharmacol Sci; 2005 May; 26(5):244-51. PubMed ID: 15860371
[TBL] [Abstract][Full Text] [Related]
31. A 5'-distal enhanceosome in the PDGF-A gene is activated in choriocarcinoma cells via ligand-independent binding of vitamin D receptor and constitutive jun kinase signaling.
Pedigo NG; Zhang H; Bruno ME; Kaetzel CS; Dugan AR; Shanehsaz P; Hennigan RF; Xing Z; Koszewski NJ; Kaetzel DM
Oncogene; 2005 Apr; 24(16):2654-66. PubMed ID: 15829977
[TBL] [Abstract][Full Text] [Related]
32. Therapeutic applications for novel non-hypercalcemic vitamin D receptor ligands.
Choi M; Makishima M
Expert Opin Ther Pat; 2009 May; 19(5):593-606. PubMed ID: 19441936
[TBL] [Abstract][Full Text] [Related]
33. Peroxisome proliferator-activated receptors and their relevance to dermatology.
Friedmann PS; Cooper HL; Healy E
Acta Derm Venereol; 2005; 85(3):194-202. PubMed ID: 16040401
[TBL] [Abstract][Full Text] [Related]
34. Human T lymphocytes are direct targets of 1,25-dihydroxyvitamin D3 in the immune system.
Baeke F; Korf H; Overbergh L; van Etten E; Verstuyf A; Gysemans C; Mathieu C
J Steroid Biochem Mol Biol; 2010 Jul; 121(1-2):221-7. PubMed ID: 20302932
[TBL] [Abstract][Full Text] [Related]
35. Peroxisome proliferator-activated receptors (PPARs) in the control of bone metabolism.
Giaginis C; Tsantili-Kakoulidou A; Theocharis S
Fundam Clin Pharmacol; 2007 Jun; 21(3):231-44. PubMed ID: 17521292
[TBL] [Abstract][Full Text] [Related]
36. Common angiotensin receptor blockers may directly modulate the immune system via VDR, PPAR and CCR2b.
Marshall TG; Lee RE; Marshall FE
Theor Biol Med Model; 2006 Jan; 3():1. PubMed ID: 16403216
[TBL] [Abstract][Full Text] [Related]
37. Natural metabolites of 1alpha,25-dihydroxyvitamin D(3) retain biologic activity mediated through the vitamin D receptor.
Harant H; Spinner D; Reddy GS; Lindley IJ
J Cell Biochem; 2000 Apr; 78(1):112-20. PubMed ID: 10797570
[TBL] [Abstract][Full Text] [Related]
38. Elevated phosphorus modulates vitamin D receptor-mediated gene expression in human vascular smooth muscle cells.
Wu-Wong JR; Nakane M; Ma J; Ruan X; Kroeger PE
Am J Physiol Renal Physiol; 2007 Nov; 293(5):F1592-604. PubMed ID: 17715259
[TBL] [Abstract][Full Text] [Related]
39. Vitamin D receptor: key roles in bone mineral pathophysiology, molecular mechanism of action, and novel nutritional ligands.
Jurutka PW; Bartik L; Whitfield GK; Mathern DR; Barthel TK; Gurevich M; Hsieh JC; Kaczmarska M; Haussler CA; Haussler MR
J Bone Miner Res; 2007 Dec; 22 Suppl 2():V2-10. PubMed ID: 18290715
[TBL] [Abstract][Full Text] [Related]
40. [Peroxisome proliferator-activated receptors (PPAR). Antiproliferative properties].
Hojka A; Rapak A
Postepy Hig Med Dosw (Online); 2011 Jun; 65():404-13. PubMed ID: 21734325
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
